Indications for neoadjuvant radiation in esophageal adenocarcinoma: Times are changing

被引：0
作者：
Worrell, Stephanie G. [1 ]
机构：
[1] Univ Arizona, Dept Surg, Sect Thorac Surg, 1501 N Campbell Ave, Tucson, AZ 85724 USA
来源：
JTCVS TECHNIQUES | 2024年 / 25卷
关键词：
esophageal adenocarcinoma; neoadjuvant therapy; esophagectomy; PHASE-III TRIAL; PREOPERATIVE CHEMORADIATION; TRIMODALITY THERAPY; CANCER; CHEMORADIOTHERAPY; RADIOTHERAPY; CHEMOTHERAPY; SURVIVAL; SURGERY;
D O I：
10.1016/j.xjtc.2024.03.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：201 / 203
页数：3
相关论文
共 25 条
  • [1] Al-Batran SE, 2022, J CLIN ONCOL, V40
  • [2] KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer
    Bang, Yung-Jue
    Van Cutsem, Eric
    Fuchs, Charles S.
    Ohtsu, Atsushi
    Tabernero, Josep
    Ilson, David H.
    Hyung, Woo Jin
    Strong, Vivian E.
    Goetze, Thorsten Oliver
    Yoshikawa, Takaki
    Tang, Laura H.
    Hwang, Peggy May Tan
    Webb, Nancy
    Adelberg, David
    Shitara, Kohei
    [J]. FUTURE ONCOLOGY, 2019, 15 (09) : 943 - 952
  • [3] Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01)
    Cooper, JS
    Guo, MD
    Herskovic, A
    Macdonald, JS
    Martenson, JA
    Al-Sarraf, M
    Byhardt, R
    Russell, AH
    Beitler, JJ
    Spencer, S
    Asbell, SO
    Graham, MV
    Leichman, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17): : 1623 - 1627
  • [4] Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy
    Corsini, Erin M.
    Foo, Wai Chin
    Mitchell, Kyle G.
    Zhou, Nicolas
    Maru, Dipen M.
    Ajani, Jaffer A.
    Hofstetter, Wayne L.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 162 (05) : 1404 - +
  • [5] Long term results of different radiotherapy techniques and fractions for esophageal squamous cell carcinoma
    Deng, Jiaying
    Xia, Yi
    Chen, Yun
    Liu, Qi
    Chen, Weiwei
    Zhao, Kuaile
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2287 - 2294
  • [6] A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of a safety run-in-A trial of the ECOG-ACRIN Cancer Research Group (EA2174).
    Eads, Jennifer Rachel
    Weitz, Michelle
    Catalano, Paul J.
    Gibson, Michael K.
    Rajdev, Lakshmi
    Khullar, Onkar
    Lin, Steven H.
    Gatsonis, Constantine
    Wistuba, Ignacio Ivan
    Sanjeevaiah, Aravind
    Benson, Al Bowen
    Bahary, Nathan
    Spencer, Kristen Renee
    Saba, Nabil F.
    Hamilton, Stanley R.
    Staley, Charles A.
    Chakravarthy, Bapsi
    Fisher, George A.
    Wong, Terence Z.
    O'Dwyer, Peter J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Adjuvant chemotherapy versus perioperative chemotherapy (CTx) for resectable gastric signet ring cell (SRC) gastric cancer: A multicenter, randomized phase II study (PRODIGE 19).
    Eveno, Clarisse
    Adenis, Antoine
    Bouche, Olivier
    Le Malicot, Karine
    Hautefeuille, Vincent
    Faroux, Roger
    Bidault, Anne Thirot
    Egreteau, Joelle
    Meunier, Bernard
    Mabro, May
    Carrere, Nicolas
    Barriere, Nicolas
    Ben Abdelghani, Meher
    Mauvais, Francois
    Di Fiore, Frederic
    Malka, David
    Manfredi, Sylvain
    Piessen, Guillaume
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation
    Gabriel, Emmanuel
    Attwood, Kristopher
    Du, William
    Tuttle, Rebecca
    Alnaji, Raed M.
    Nurkin, Steven
    Malhotra, Usha
    Hochwald, Steven N.
    Kukar, Moshim
    [J]. JAMA SURGERY, 2016, 151 (03) : 234 - 245
  • [9] ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
    Hoeppner, Jens
    Lordick, Florian
    Brunner, Thomas
    Glatz, Torben
    Bronsert, Peter
    Roethling, Nadine
    Schmoor, Claudia
    Lorenz, Dietmar
    Ell, Christian
    Hopt, Ulrich T.
    Siewert, J. Ruediger
    [J]. BMC CANCER, 2016, 16
  • [10] MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
    Janjigian, Yelena Y.
    Van Cutsem, Eric
    Muro, Kei
    Wainberg, Zev
    Al-Batran, Salah-Eddin
    Hyung, Woo Jin
    Molena, Daniela
    Marcovitz, Michelle
    Ruscica, Dario
    Robbins, Scott H.
    Negro, Alejandra
    Tabernero, Josep
    [J]. FUTURE ONCOLOGY, 2022, 18 (20) : 2465 - 2473
123